3.87
前日終値:
$3.88
開ける:
$3.86
24時間の取引高:
1.24M
Relative Volume:
1.22
時価総額:
$187.16M
収益:
$219.42M
当期純損益:
$-15.09M
株価収益率:
-9.3051
EPS:
-0.4159
ネットキャッシュフロー:
$-3.05M
1週間 パフォーマンス:
-14.00%
1か月 パフォーマンス:
-14.95%
6か月 パフォーマンス:
+8.10%
1年 パフォーマンス:
-64.33%
Lifemd Inc Stock (LFMD) Company Profile
Compare LFMD vs VEEV, BTSG, TEM, HQY, TXG
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
LFMD
Lifemd Inc
|
3.87 | 187.65M | 219.42M | -15.09M | -3.05M | -0.4159 |
|
VEEV
Veeva Systems Inc
|
179.58 | 29.98B | 3.32B | 941.65M | 1.64B | 5.6161 |
|
BTSG
Brightspring Health Services Inc
|
69.84 | 13.69B | 13.65B | 169.86M | 412.12M | 1.0758 |
|
TEM
Tempus Ai Inc
|
46.01 | 8.46B | 1.36B | -302.91M | -219.93M | -1.7182 |
|
HQY
Healthequity Inc
|
94.33 | 8.02B | 1.34B | 230.70M | 440.96M | 2.6695 |
|
TXG
10 X Genomics Inc
|
48.06 | 5.97B | 638.78M | -22.66M | 122.18M | -0.1744 |
Lifemd Inc Stock (LFMD) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-16 | アップグレード | Mizuho | Neutral → Outperform |
| 2025-06-18 | 繰り返されました | BTIG Research | Buy |
| 2024-12-10 | 開始されました | Lake Street | Buy |
| 2024-12-04 | 開始されました | Mizuho | Neutral |
| 2024-08-23 | 再開されました | B. Riley Securities | Buy |
| 2024-06-05 | 開始されました | KeyBanc Capital Markets | Overweight |
| 2023-11-30 | 開始されました | Craig Hallum | Buy |
| 2023-07-21 | 開始されました | Cantor Fitzgerald | Overweight |
| 2023-07-03 | 開始されました | H.C. Wainwright | Buy |
| 2022-03-10 | 開始されました | Colliers Securities | Buy |
| 2021-10-04 | 再開されました | B. Riley Securities | Buy |
すべてを表示
Lifemd Inc (LFMD) 最新ニュース
Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers say - STAT
FEDERATED HERMES, INC. Acquires Significant Stake in LifeMD Inc - GuruFocus
LFMD News | LIFEMD INC (NASDAQ:LFMD) - ChartMill
LifeMD Inc. (LFMD) Declines 1.9%, Testing Key Support Near $4.41Volume Climax - dars.gov.et
B. Riley Names Top Digital Health Stock to Buy By Investing.com - Investing.com Australia
B. Riley Names Top Digital Health Stock to Buy - Investing.com India
LifeMD Rings the Nasdaq Stock Market Closing Bell - Nasdaq
LifeMD Rings the Closing Bell - Nasdaq
Federated Hermes reports 2.75M-share stake in LifeMD (LFMD) - Stock Titan
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beats Estimates Amid Revenue Disclosure GapConsensus Miss Rate - dars.gov.et
LifeMD, Inc. (NASDAQ:LFMD): Can the Penny Stock Story Continue? - Kalkine Media
LFMDP Q1 2026 Earnings: Narrower-Than-Expected Loss Sends Preferred Stock Slightly LowerGuidance Accuracy Score - dars.gov.et
Undiscovered Opportunities Penny Stocks To Consider In July 2026 - Sahm
(LFMD) Volatility Zones as Tactical Triggers - Stock Traders Daily
LFMDP Q1 2026 Earnings: Narrower Loss Surprises as Preferred Stock DeclinesEarnings Call Transcript - dars.gov.et
LifeMD Inc. (LFMDP) Q1 2026 Earnings: Preferred Shares Dip Despite Narrower-Than-Expected LossRevenue Guidance Range - dars.gov.et
LFMD Q1 2026 Earnings: EPS Surpasses Estimates Despite Lack of Revenue DisclosureEarnings Yield Spread - dars.gov.et
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion By Investing.com - Investing.com South Africa
B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10 - Moomoo
B.Riley reiterates LifeMD stock Buy rating on telehealth expansion - Investing.com
LifeMD Inc. (LFMD) Q1 2026 Earnings: EPS Beat Partially Offsets Revenue UncertaintyTangible Book Value - dars.gov.et
LFMD SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Anno - The National Law Review
LFMD INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announc - The National Law Review
LifeMD Inc. (LFMD) Q1 2026 Earnings: Narrower-Than-Expected Loss Signals Improved Cost DisciplineConsensus Beat Rate - dars.gov.et
LFMDP Q1 2026 Earnings: Preferred Stock Benefiting from Improved Operational Performance as Loss Narrower Than ExpectedQuarterly Earnings Report - dars.gov.et
Enterprise value to revenue forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to book forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
Price to sales forward of LifeMD, Inc. – NASDAQ:LFMD - TradingView
LIFEMD INC PFD SER A 8.875% To Go Ex-Dividend On July 2nd, 2026 With 0.55469 USD Dividend Per Share - 富途牛牛
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock - Sahm
Best GLP-1 Medical Weight Loss Clinics in 2026 | Good Life Health - marketscreener.com
LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection - Sahm
LifeMD, Inc. And Antares Pharma, Inc. Launch Direct-To-Patient Self-Pay Program For XYOSTED (Testosterone Enanthate) Injection - marketscreener.com
LifeMD Partners with Antares on XYOSTED Telehealth Program - TipRanks
LifeMD partners with Antares Pharma on testosterone program By Investing.com - Investing.com Nigeria
Form 8K LifeMD Inc For: 22 June By Investing.com - Investing.com South Africa
LifeMD partners with Antares Pharma on testosterone program - Investing.com
LifeMD to Launch Exclusive XYOSTED Self-Pay Telehealth Program in July across 37 States - TradingView
LifeMD (Nasdaq: LFMD) inks exclusive telehealth collaboration for XYOSTED self-pay program - Stock Titan
LifeMD and Halozyme Announce Exclusive Telehealth Co-Marketing Agreement for XYOSTED Self-Pay Program Launching in July 2026 - Quiver Quantitative
LifeMD, Halozyme link up to sell testosterone therapy online - Stock Titan
LifeMD Inc (LFMD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
LifeMD Inc (LFMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
LifeMD Inc (LFMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
LifeMD Inc (LFMD) Valuation: PE, PB & Fair Value Analysis - TradingKey
LifeMD Inc (LFMD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
LifeMD Inc (LFMD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
LifeMD Inc (LFMD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
LifeMD Inc (LFMD) Institutional Confidence - TradingKey
LifeMD Inc (LFMD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
LifeMD (LFMD) Sheds Value: Testing Near-Term Support After 1.83% DeclineATR Stop - DonanımHaber
Lifemd Inc (LFMD) 財務データ
収益
当期純利益
現金流量
EPS
Lifemd Inc (LFMD) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| FRIEDEMAN JESSICA | Chief Marketing Officer |
Dec 09 '25 |
Sale |
3.61 |
15,000 |
54,158 |
205,000 |
大文字化:
|
ボリューム (24 時間):